Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases

In-hospital medical complications associated with stroke recurrence after initial ischemic stroke: A prospective cohort study from the China National Stroke Registry

First author:Penglian Wang

Corresponding author:Yongjun Wang

Complication ischemic stroke outcome recurrent

essential_information

  • Person in charge:Penglian Wang
  • Data Sources: CNSR-I
  • Number of papers:CNSR-I20190159
  • Published time:2016-09-05

2016-09-05

Published articles

Journal:Medicine

Publication type: Original Contributions

IF(IF): 1.889

PMID: 27631271 Link To Pubmed Full text Download

Background And Purpose

In-hospital medical complications are common and strongly associated with the risk of death and dependency in stroke patients. Whether similar associations extend to stroke recurrence is unclear. We prospectively and systematically investigated whether in-hospital medical complications are associated with recurrent stroke of patients in the China National Stroke Registry (CNSR).

Method

We examined patients with initial ischemic stroke enrolled in CNSR between 2007 and 2008. Recurrent stroke at 3, 6, and 12 months post-stroke was used as stroke outcome. Medical complications were associated with stroke outcomes using multivariable logistic regression.

Conclusion

The persistence of secondary prevention medications in patients with complications was lower than that in patients without complications.Stroke recurrence post-acute ischemic stroke is significantly associated with in-hospital medical complications.

Main results

Of the 7593 study patients, recurrent stroke occurred in 1115 (14.7%) within 12 months after stroke onset. In-hospital medical complications were independent risk factors for stroke recurrence in patients with initial ischemic stroke at 3 months (adjusted odds ratio (OR) = 2.19, 95% confidence interval (CI) 1.85 to 2.60), 6 months (adjusted OR = 2.04, 95% CI 1.74 to 2.38), and 12 months (adjusted OR = 1.88; 95% CI 1.62 to 2.19) after onset.